1. Home
  2. JAGX vs IVP Comparison

JAGX vs IVP Comparison

Compare JAGX & IVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
  • IVP
  • Stock Information
  • Founded
  • JAGX 2013
  • IVP 2020
  • Country
  • JAGX United States
  • IVP United States
  • Employees
  • JAGX N/A
  • IVP N/A
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • IVP Diversified Commercial Services
  • Sector
  • JAGX Health Care
  • IVP Miscellaneous
  • Exchange
  • JAGX Nasdaq
  • IVP Nasdaq
  • Market Cap
  • JAGX 3.1M
  • IVP 3.0M
  • IPO Year
  • JAGX N/A
  • IVP 2023
  • Fundamental
  • Price
  • JAGX $4.67
  • IVP $1.74
  • Analyst Decision
  • JAGX
  • IVP
  • Analyst Count
  • JAGX 0
  • IVP 0
  • Target Price
  • JAGX N/A
  • IVP N/A
  • AVG Volume (30 Days)
  • JAGX 39.3K
  • IVP 92.7K
  • Earning Date
  • JAGX 03-31-2025
  • IVP 05-14-2025
  • Dividend Yield
  • JAGX N/A
  • IVP N/A
  • EPS Growth
  • JAGX N/A
  • IVP N/A
  • EPS
  • JAGX N/A
  • IVP N/A
  • Revenue
  • JAGX $11,689,000.00
  • IVP $16,592,109.00
  • Revenue This Year
  • JAGX $18.18
  • IVP N/A
  • Revenue Next Year
  • JAGX $40.06
  • IVP N/A
  • P/E Ratio
  • JAGX N/A
  • IVP N/A
  • Revenue Growth
  • JAGX 19.75
  • IVP 6.12
  • 52 Week Low
  • JAGX $4.40
  • IVP $1.60
  • 52 Week High
  • JAGX $540.00
  • IVP $401.50
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 20.41
  • IVP 36.63
  • Support Level
  • JAGX $4.41
  • IVP $1.60
  • Resistance Level
  • JAGX $4.97
  • IVP $1.76
  • Average True Range (ATR)
  • JAGX 0.88
  • IVP 0.12
  • MACD
  • JAGX 0.09
  • IVP 0.02
  • Stochastic Oscillator
  • JAGX 3.35
  • IVP 25.00

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About IVP Inspire Veterinary Partners Inc.

Inspire Veterinary Partners Inc owns and operates veterinary hospitals throughout the United States. The company specializes in small animal general practice hospitals that serve all manner of companion pets, emphasizing canine and feline breeds.

Share on Social Networks: